243 related articles for article (PubMed ID: 2989314)
21. Interaction of thyroid-stimulating antibody with Graves' thyroid-stimulating hormone-binding antibody.
Ochi Y; Kajita Y; Hamazu M; Nagata A
Horm Res; 2003; 59(5):222-8. PubMed ID: 12714785
[TBL] [Abstract][Full Text] [Related]
22. Photoaffinity labelling of the porcine thyrotropin receptor--effect of Graves' immunoglobulin G and anti-TSH anti-idiotypic antibodies.
Bakó G; Islam MN; Farid NR
Clin Invest Med; 1985; 8(2):152-9. PubMed ID: 2870832
[TBL] [Abstract][Full Text] [Related]
23. Anti-TSH antibodies in Graves' disease and their failure to interact with TSH receptor antibodies.
Ochi Y; Nagamune T; Nakajima Y; Ishida M; Kajita Y; Hachiya T; Ogura H
Acta Endocrinol (Copenh); 1989 Jun; 120(6):773-7. PubMed ID: 2567103
[TBL] [Abstract][Full Text] [Related]
24. Thyroid-stimulating antibodies in sera from patients with Graves' disease are heterogeneous in epitope recognition.
Ueda Y; Sugawa H; Akamizu T; Okuda J; Ueda M; Kosugi S; Ohta C; Kihou Y; Mori T
Eur J Endocrinol; 1995 Jan; 132(1):62-8. PubMed ID: 7531576
[TBL] [Abstract][Full Text] [Related]
25. Radioreceptor assay of anti-TSH receptor antibody activity: comparison of assays using unextracted serum and immunoglobulin fractions, and standardization of expression of activities.
Tamaki H; Amino N; Watanabe Y; Aozasa M; Hayashi H; Tachi J; Miyai K
J Clin Lab Immunol; 1986 May; 20(1):1-6. PubMed ID: 3016274
[TBL] [Abstract][Full Text] [Related]
26. Interference with thyrotropin receptor antibody determination by a spuriously occurring anti-bovine TSH antibody.
Iitaka M; Tanikawa T; Sakatsume Y; Yanagisawa M; Hara Y; Ishii J
Acta Endocrinol (Copenh); 1986 Jun; 112(2):197-203. PubMed ID: 2874680
[TBL] [Abstract][Full Text] [Related]
27. Serum protein inhibition of thyrotropin binding to human thyroid tissue.
Beall GN; Chopra IJ; Solomon DH; Kruger SR
J Clin Endocrinol Metab; 1978 Nov; 47(5):967-73. PubMed ID: 45474
[TBL] [Abstract][Full Text] [Related]
28. Human thyrotropin receptor subunits characterized by thyrotropin affinity purification and western blotting.
Leedman PJ; Newman JD; Harrison LC
J Clin Endocrinol Metab; 1989 Jul; 69(1):134-41. PubMed ID: 2471709
[TBL] [Abstract][Full Text] [Related]
29. The putative anti-thyrotropin receptor antibodies of Graves' disease. I. Gm allotypes.
Pepper B; Noel EP; Farid NR
J Immunogenet; 1981 Apr; 8(2):89-100. PubMed ID: 6262412
[TBL] [Abstract][Full Text] [Related]
30. The antibodies causing thyroid stimulating hormone-binding inhibition (TSH-BI) are not responsible for the specific inhibition of gonadal steroidogenesis by Graves' sera.
Castel MA; Willey KP; Hunt N; Leidenberger F
J Reprod Immunol; 1996 Feb; 30(1):1-15. PubMed ID: 8920164
[TBL] [Abstract][Full Text] [Related]
31. TSH receptor binding and thyroid stimulation by sera from patients with Graves' disease.
Ginsberg J; Shewring G; Smith BR
Clin Endocrinol (Oxf); 1983 Sep; 19(3):305-11. PubMed ID: 6138173
[TBL] [Abstract][Full Text] [Related]
32. Stimulating and blocking thyroid-stimulating hormone (TSH) receptor autoantibodies from patients with Graves' disease and autoimmune hypothyroidism have very similar concentration, TSH receptor affinity, and binding sites.
Morgenthaler NG; Ho SC; Minich WB
J Clin Endocrinol Metab; 2007 Mar; 92(3):1058-65. PubMed ID: 17179194
[TBL] [Abstract][Full Text] [Related]
33. Evidence that TSH Receptor A-Subunit Multimers, Not Monomers, Drive Antibody Affinity Maturation in Graves' Disease.
Rapoport B; Aliesky HA; Chen CR; McLachlan SM
J Clin Endocrinol Metab; 2015 Jun; 100(6):E871-5. PubMed ID: 25856215
[TBL] [Abstract][Full Text] [Related]
34. Anti-thyroglobulin anti-idiotypic antibodies in sera of patients with Hashimoto's thyroiditis and Graves' disease.
Sikorska HM
J Immunol; 1986 Dec; 137(12):3786-95. PubMed ID: 3782795
[TBL] [Abstract][Full Text] [Related]
35. An anti-idiotypic antibody against Graves' IgG.
Hawe BS; Davies TF; Farid NR
Immunol Lett; 1987 Jun; 15(2):95-100. PubMed ID: 2442098
[TBL] [Abstract][Full Text] [Related]
36. Soluble ecto-domain mutant of thyrotropin (TSH) receptor incapable of binding TSH neutralizes the action of thyroid-stimulating antibodies from Graves' patients.
Osuga Y; Liang SG; Dallas JS; Wang C; Hsueh AJ
Endocrinology; 1998 Feb; 139(2):671-6. PubMed ID: 9449640
[TBL] [Abstract][Full Text] [Related]
37. Graves' immunoglobulins protect the human TSH receptor: further evidence for TSH receptor antibodies in Graves' disease.
Davies TF; Platzer M
Clin Endocrinol (Oxf); 1983 Oct; 19(4):427-35. PubMed ID: 6313261
[TBL] [Abstract][Full Text] [Related]
38. Estimation of serum TSH receptor autoantibody concentration and affinity.
Nakatake N; Sanders J; Richards T; Burne P; Barrett C; Pra CD; Presotto F; Betterle C; Furmaniak J; Smith BR
Thyroid; 2006 Nov; 16(11):1077-84. PubMed ID: 17123333
[TBL] [Abstract][Full Text] [Related]
39. Membrane-binding antibodies in patients with Graves' disease and other autoimmune diseases.
Tao TW; Kriss JP
J Clin Endocrinol Metab; 1982 Nov; 55(5):935-40. PubMed ID: 6126489
[TBL] [Abstract][Full Text] [Related]
40. Epitope mapping of tsh receptor-blocking antibodies in Graves' disease that appear during pregnancy.
Kung AW; Lau KS; Kohn LD
J Clin Endocrinol Metab; 2001 Aug; 86(8):3647-53. PubMed ID: 11502791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
